Levosimendan als Rescue-Therapie bei akutem primären Transplantatversagen nach Herztransplantation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery
Link
http://link.springer.com/content/pdf/10.1007/s00398-007-0594-0.pdf
Reference13 articles.
1. Mitropoulos FA, Odim J, Marelli D, Karandikar K, Gjertson D, Ardehali A et al (2005) Outcome of hearts with cold ischemic time greater than 300 min. A case-matched study. Eur J Cardiothorac Surg 28(1):143–148
2. Deng MC, Edwards LB, Hertz MI, Rowe AW, Keck BM, Korkos R et al (2005) Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report – 2005. J Heart Lung Transplant 24(9):1182–1187
3. Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K et al (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360:196–202
4. Brixius K, Hoyer HK, Schwinger RH (2005) Ca(2+)-sensitisers-a promising option to treat heart failure? Cardiovasc Drugs Ther 19(6):423–428
5. Moiseyev VS, Poder P, Andrejevs N, Ruda MY, Golikov AP, Lazebnik LB et al (2002) Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J 23:1422–1432
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3